Work with the world's top founders

resistanceBio
resistanceBio
resistance.bio

Locations

Menlo Park, CA, USA

industry

Biotechnology · DeepTech · Health

Size

1 - 10 employees

Stage

Other

founded in

2019

Resistance Bio is the first platform that generates real resistance data to solve drug resistance, which is responsible for 90% of cancer mortality. The company focuses on understanding and preventing drug resistance from the start, recognizing that while drugs are tested for 2-4 weeks, clinical resistance can take over 3 months to evolve. By combining advanced biotechnology with long-term evolution, Resistance Bio aims to develop longer-lasting drugs, reveal resistance pathways, discover novel targets, and predict clinical outcomes, ultimately advancing drug candidates and approving new drugs faster and cheaper. The market size for ALK in lung cancer is around $3.5 billion, with potential for significant growth through the use of resistance data.


Is this your company?

If you're responsible for hiring at this company, make sure your company and job information are always up to date to attract top talent from the NFX Guild network.

Something looks off?
Open jobs at resistanceBio
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.